Dow Up 0.12% Nasdaq Up 1.35%

Synta Pharmaceuticals Corp. (SNTA)

-NasdaqGM
3.13 Up 0.11(3.47%) 4:00PM EDT
Prev Close:3.03
Open:3.01
Bid:2.90 x 20000
Ask:3.22 x 5000
1y Target Est:12.50
Beta:1.42
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:3.00 - 3.23
52wk Range:2.62 - 7.22
Volume:1,052,558
Avg Vol (3m):1,430,230
Market Cap:326.67M
P/E (ttm):N/A
EPS (ttm):-1.14
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for SNTA

Comparison

Symbol% ChgMkt Cap
SNTAUp 3.47%326.67M
INFIUp 1.33%629.19M
NVSUp 1.47%213.26B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.02
Quarterly EPS Est (Sep-14) :-0.24
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs for treating severe medical conditions, including cancer and chronic inflammatory diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback